Increased serum tau levelwas seen in patients with cognitive decline after CPB, and increasedcerebrospinal fluid βAP and tau levels were similarto those having Alzheimer's disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.